Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukemia
Results from an multi-institutional, phase 3 clinical trial show that older patients with chronic lymphocytic leukemia (CLL) have a significantly lower rate of disease progression if treated with the newer targeted drug, ...
Dec 3, 2018
0
25